Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vadim Khaychuk

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|July 15, 2021
Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic TherapiesMir Sohail Fazeli, Vadim Khaychuk, Keith Wittstock, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscapeMir Sohail Fazeli, Vadim Khaychuk, Keith Wittstock, et al.
Rheumatology and Therapy|February 7, 2023
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCPLeslie R Harrold, Keith Wittstock, Sheila Kelly, et al.
Seminars in Arthritis and Rheumatism|August 13, 2023
Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic reviewJeffrey A Sparks, Leslie R Harrold, Teresa A Simon, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2019
Primary structural differences at residue 226 of deer and elk PrP dictate selection of distinct CWD prion strains in gene-targeted miceJifeng Bian, Jeffrey R Christiansen, Julie A Moreno, et al.
Advances in Rheumatology (London, England)|January 19, 2024
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positiveLeslie R Harrold, Keith Wittstock, Sheila Kelly, et al.
Rheumatology (Oxford, England)|July 11, 2025
Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasisQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2025
Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A comparative cohort studyQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Plos One|April 6, 2011
In vitro amplification of misfolded prion protein using lysate of cultured cellsCharles E Mays, Jihyun Yeom, Hae-Eun Kang, et al.
Rheumatology and Therapy|December 23, 2021
Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RALeslie R Harrold, Sean E Connolly, Keith Wittstock, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|July 15, 2021
Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic TherapiesMir Sohail Fazeli, Vadim Khaychuk, Keith Wittstock, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscapeMir Sohail Fazeli, Vadim Khaychuk, Keith Wittstock, et al.
Rheumatology and Therapy|February 7, 2023
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCPLeslie R Harrold, Keith Wittstock, Sheila Kelly, et al.
Seminars in Arthritis and Rheumatism|August 13, 2023
Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic reviewJeffrey A Sparks, Leslie R Harrold, Teresa A Simon, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2019
Primary structural differences at residue 226 of deer and elk PrP dictate selection of distinct CWD prion strains in gene-targeted miceJifeng Bian, Jeffrey R Christiansen, Julie A Moreno, et al.
Advances in Rheumatology (London, England)|January 19, 2024
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positiveLeslie R Harrold, Keith Wittstock, Sheila Kelly, et al.
Rheumatology (Oxford, England)|July 11, 2025
Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasisQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2025
Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A comparative cohort studyQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Plos One|April 6, 2011
In vitro amplification of misfolded prion protein using lysate of cultured cellsCharles E Mays, Jihyun Yeom, Hae-Eun Kang, et al.
Rheumatology and Therapy|December 23, 2021
Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RALeslie R Harrold, Sean E Connolly, Keith Wittstock, et al.
Pageof 3